Genmab A/S Gross Margin Growth & History (GMAB)
Genmab A/S's gross margin was 93.60% for fiscal 2025.
View full Genmab A/S company overviewGenmab A/S annual gross margin history
2023
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 93.60% | −1.82 pp |
| 2024 | 2024-12-31 | 95.42% | −3.20 pp |
| 2023 | 2023-12-31 | 98.62% | — |
Genmab A/S quarterly gross margin
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 92.73% | −1.11 pp |
| Q1 2026 | 2026-03-31 | 92.75% | — |
| Q4 2025 | 2025-12-31 | 92.34% | — |
| Q3 2025 | 2025-09-30 | 94.32% | — |
| Q2 2025 | 2025-06-30 | 93.84% | −2.57 pp |
| Q2 2024 | 2024-06-30 | 96.41% | — |
Genmab A/S gross margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Genmab A/S's gross margin decreased from 98.62% to 93.60%, a change of −5.02 percentage points. The latest reported quarter, Q2 2026, shows 92.73%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genmab A/S source filings ↗